Akums Drugs and Pharmaceuticals Ltd is expanding its operations by establishing a new division in Mumbai with an investment of approximately 270 million rupees. This move aims to enhance the company's manufacturing capabilities and market presence.
To further boost its export business, Akums Drugs and Pharmaceuticals plans to incorporate subsidiaries in Jammu & Kashmir (I-JK) and Malta. These incorporations will strategically position the company to tap into new markets and streamline its international operations.
In related expansions, Akums is setting up two dry powder injection lines with a total investment of 475 million rupees. This development will significantly increase production capacity for specialized pharmaceutical products.
The company's strong financial performance is reflected in its December quarter consolidated net profit of 651.8 million rupees, demonstrating robust growth and efficient operations.
These strategic initiatives underscore Akums Drugs & Pharmaceuticals' commitment to growth, innovation, and expanding its global footprint.
Source: Akums Drugs and Pharmaceuticals Ltd, BSEIndia, ICRA